Article: Mitsubishi Pharma, Tanabe weigh merger around October.

Jan. 19--OSAKA -- Mitsubishi Pharma Corp., a wholly owned subsidiary of Mitsubishi Chemical Holdings Corp., is discussing merging with another drugmaker, Tanabe Seiyaku Co., around October, the companies said Thursday.

The deal being contemplated is expected to catapult the merged firm into sixth place in Japan's pharmaceutical industry amid intensifying competition at home and abroad, industry observers say.

Asked about merging in October, a Mitsubishi Pharma source said, "If we try to do it soon, I think it's possible." Mitsubishi Pharma ranks ninth in the business in terms of sales and Tanabe 11th, and their combined sales are estimated at 400 billion ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!